Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
about
Current Status of the New Antiepileptic Drugs in Chronic PainPregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain.Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials.Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines.The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system.Pregabalin in neuropathic pain: evidences and possible mechanisms.Drug safety evaluation of pregabalin.Neuropathic pain and pharmacological treatment.Evidence-based guidance for the management of postherpetic neuralgia in primary care.Calcium-permeable ion channels in pain signaling.Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials.The Anti-Allodynic Gabapentinoids: Myths, Paradoxes, and Acute Effects.Improvement in pain severity category in clinical trials of pregabalinPregabalin for the treatment of neuropathic pain: a narrative review for primary care providers.A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients.Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgia.Analysis of the long-term actions of gabapentin and pregabalin in dorsal root ganglia and substantia gelatinosa.Does Duration of Neuropathic Pain Impact the Effectiveness of Pregabalin?Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients
P2860
Q28070254-82547712-1703-49FF-94F3-DC63932715E3Q33949565-587C6291-BF96-4F93-B127-D9B5C8D7945FQ34411257-279B7B41-530C-4E6B-BAF3-32F3BBBA02B1Q35061149-AD2EDE6A-92A8-4FE1-9824-1F8D6D89BFE4Q35694450-D5344763-8901-44A2-BBDD-9B7B8A2238C9Q35948021-7CAB1688-8FA9-4E46-86BD-441AD8BFBB62Q35974778-CCC5CB0A-6087-4B53-866C-D7473EF3D95EQ37559818-97E8650B-E30D-4215-A05D-73E66DE58593Q37999052-ACD4749C-59F8-477C-9150-A91808D253BEQ38113229-2ED6EB8D-40D9-4EFA-86D5-2E9D1BDD070BQ38128177-759E785B-5331-473C-B893-045CC689B92BQ38175134-8F43C386-864D-46D4-8E57-017E01905427Q38631470-76B3B35D-FE43-4C26-990B-207E63C748D4Q38818781-001675BA-F8E6-4636-9C0B-464244A1C583Q39165164-9EB82A21-D160-4B49-8D27-79489565CA30Q39252064-9AFEE551-E8D5-4F01-902F-D18AEC5AC863Q47905583-6FECE134-5173-43D8-9A41-56C8B52E7BB9Q48006388-CD588DDD-A5EF-4BC5-87A8-715EAD00D643Q50627864-75F7252C-3E14-4787-9262-51CEABB5AADBQ51826259-6ADC0AE0-049F-4D14-8A94-43A8044AEB0AQ58767868-EAC2B0FC-EBD0-4A53-AA11-88DAD8D86DE9
P2860
Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@ast
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@en
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@nl
type
label
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@ast
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@en
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@nl
prefLabel
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@ast
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@en
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@nl
P2093
P1476
Time to onset of neuropathic p ...... hy and postherpetic neuralgia.
@en
P2093
Birol Emir
James P Young
Teresa Griesing
Uma Sharma
P304
P356
10.1097/MJT.0B013E3181D5E4F3
P577
2010-11-01T00:00:00Z